क्यूआर कोड

Art of TIL immunotherapy: SITC’s perspective on demystifying a complex treatment

In a first for solid cancers, cellular immunotherapy has entered standard of care in the treatment of patients with metastatic melanoma. The infusion of autologous tumor-infiltrating T lymphocytes (TIL) is capable of mediating durable tumor regression and is now Food and Drug Administration-approved...

पूर्ण विवरण

में बचाया:
मुख्य लेखकों: Robert Brown, Marco Donia, Simon Turcotte, George Coukos, John Mullinax, Brian Gastman, James C Yang, Michael T Lotze, John B A G Haanen, Inge Marie Svane, Stephanie L Goff, Vernon K Sondak, Maartje W Rohaan, Michal Besser, Benjamin Creelan
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BMJ Publishing Group 2025-01-01
श्रृंखला:Journal for ImmunoTherapy of Cancer
ऑनलाइन पहुंच:https://jitc.bmj.com/content/13/1/e010207.full
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन